Related Experiment Video
Updated: May 5, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Field Cancerisation in Oral Squamous Cell Carcinoma Patients: A Systematic Review
Ezhilarasi Sundaram1, Uma Shankar Pal2, Meleti Venkata Sowmya3
1Department of Oral and Maxillofacial Surgery, Faculty of Dental Science, King George Medical University, Lucknow, Uttar Pradesh 226003 India.
Field cancerisation in the oral cavity involves molecular changes in normal-appearing tissue, often leading to recurrence. Ki-67 is the most reliable biomarker for identifying these changes and predicting patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Oral Pathology
Background:
- Field cancerisation describes molecular alterations in clinically normal tissue, increasing oral cancer risk due to carcinogen exposure.
- This phenomenon contributes to local recurrence and the development of second primary tumors after initial treatment.
Purpose of the Study:
- To identify the most frequently used biomarkers for oral cavity field cancerisation.
- To determine the prognostic significance of these biomarkers.
Main Methods:
- A systematic review was conducted following PRISMA guidelines, searching PubMed, Web of Science, and Google Scholar.
- Twenty-three articles were included after independent review and full-text analysis, with bias assessed using the JBI checklist.
Main Results:
- Commonly assessed biomarkers include Ki-67, p53, cyclin-D1, E-Cadherin, α-SMA, mi-RNAs, chromosomal polysomy, and gene methylations.
- Ki-67 and p53 were most frequently used, but Ki-67 demonstrated a more confirmed role in identifying field changes.
- Ki-67 is an established independent prognostic indicator for loco-regional control and disease-free survival.
Conclusions:
- Ki-67 is a valuable biomarker for oral cavity field cancerisation, offering prognostic information.
- Further prospective studies are necessary to fully elucidate the predictive role of various biomarkers for loco-regional recurrences and second primary oral cancers.
Related Concept Videos
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Survival Analysis

